These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38617588)

  • 21. Value of detecting peri-device leak and incomplete endothelialization by cardiac CT angiography in atrial fibrillation patients post Watchman LAAC combined with radiofrequency ablation.
    Zhao MZ; Chi RM; Yu Y; Wang QS; Sun J; Li W; Zhang PP; Liu B; Feng XF; Zhao Y; Mo BF; Chen M; Zhang R; Gong CQ; Yu YC; Li YG
    J Cardiovasc Electrophysiol; 2021 Oct; 32(10):2655-2664. PubMed ID: 34428342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous closure of a 'whale tail' left atrial appendage with a Watchman FLX device and pre-procedural FEops HEARTguide patient-specific computational simulation: a case report.
    Di Muro FM; Stolcova M; Di Mario C; Meucci F
    Eur Heart J Case Rep; 2022 May; 6(5):ytac176. PubMed ID: 35528127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.
    Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J
    Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transesophageal echocardiographic diagnosis of a WATCHMAN left atrial appendage closure device thrombus 10 years following implantation.
    Shamim S; Magalski A; Chhatriwalla AK; Allen KB; Huber KC; Main ML
    Echocardiography; 2017 Jan; 34(1):128-130. PubMed ID: 27862233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transition from WATCHMAN V.2.5 to WATCHMAN FLX for closure of the left atrial appendage: echocardiographic and clinical findings.
    Sakriss C; Roehl P; Schwenzky A; Hoyme M; Ebelt H
    Open Heart; 2023 Mar; 10(1):. PubMed ID: 36918230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and predictors of device-related thrombus after left atrial appendage closure with Watchman device.
    Maksym J; Scisło P; Kapłon-Cieślicka A; Huczek Z; Marchel M; Kochman J; Zbroński K; Opolski G; Grabowski M; Mazurek T
    Postepy Kardiol Interwencyjnej; 2024 Jun; 20(2):164-171. PubMed ID: 39022721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amulet device implantation following incomplete left atrial appendage closure with Watchman legacy device.
    Yoon SH; Elgendy AY; Dallan LAP; Filby SJ
    Catheter Cardiovasc Interv; 2024 Jan; 103(1):226-229. PubMed ID: 37870093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gender differences in outcomes after left atrial appendage closure with Watchman FLX device: insights from the Italian-FLX registry.
    Bonanni M; Frazzetto M; Nardone A; Meucci F; Musto C; Quaranta G; Saccà S; Bedogni F; Maffeo D; Ugo F; Guarracini F; Bocuzzi G; Durante A; Granatelli A; Tumminello G; Eusebio G; Grasso C; De Marco F; Cortese B; Mariani M; Berti S
    Front Cardiovasc Med; 2024; 11():1419018. PubMed ID: 39139754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence, Characteristics, and Clinical Course of Device-Related Thrombus After Watchman Left Atrial Appendage Occlusion Device Implantation in Atrial Fibrillation Patients.
    Kubo S; Mizutani Y; Meemook K; Nakajima Y; Hussaini A; Kar S
    JACC Clin Electrophysiol; 2017 Dec; 3(12):1380-1386. PubMed ID: 29759668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of intracardiac vs. transesophageal echocardiography for "one-stop" procedures of combined radiofrequency catheter ablation and left atrial appendage closure with the Watchman device in the treatment of atrial fibrillation.
    Shang X; Sun M; Wang Z; Jin Z; Liang M
    Front Cardiovasc Med; 2023; 10():1265550. PubMed ID: 38028460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous left atrial appendage closure in patients with primary hemostasis disorders and atrial fibrillation.
    Dognin N; Salaun E; Champagne C; Domain G; O'Hara G; Philippon F; Paradis JM; Faroux L; Beaudoin J; O'Connor K; Bernier M; Rodés-Cabau J; Champagne J
    J Interv Card Electrophysiol; 2022 Aug; 64(2):497-509. PubMed ID: 34822043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed endothelialization of watchman device identified with cardiac CT.
    Sivasambu B; Arbab-Zadeh A; Hays A; Calkins H; Berger RD
    J Cardiovasc Electrophysiol; 2019 Aug; 30(8):1319-1324. PubMed ID: 31257658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes.
    Dukkipati SR; Kar S; Holmes DR; Doshi SK; Swarup V; Gibson DN; Maini B; Gordon NT; Main ML; Reddy VY
    Circulation; 2018 Aug; 138(9):874-885. PubMed ID: 29752398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left atrial appendage closure in patients with reversed chicken-wing morphology: Anatomical features and procedural strategy.
    Yang M; Chen M; Gong CQ; Li W; Zhang PP; Zhang R; Mo BF; Ding HR; Wang QS; Lu QF; Sun J; Li YG
    Heliyon; 2023 Jan; 9(1):e12662. PubMed ID: 36691523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computed tomography measurement of the left atrial appendage for optimal sizing of the Watchman device.
    Xu B; Betancor J; Sato K; Harb S; Abdur Rehman K; Patel K; Kumar A; Cremer PC; Jaber W; Rodriguez LL; Schoenhagen P; Wazni O
    J Cardiovasc Comput Tomogr; 2018; 12(1):50-55. PubMed ID: 29223726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three-dimensional intracardiac echocardiography for left atrial appendage sizing and percutaneous occlusion guidance.
    Della Rocca DG; Magnocavallo M; Gianni C; Mohanty S; Al-Ahmad A; Bassiouny M; Denora M; La Fazia VM; Lavalle C; Gallinghouse GJ; Santangeli P; Polselli M; Sarkozy A; Vetta G; Ahmed A; Sanchez JE; Pannone L; Chierchia GB; Tschopp DR; de Asmundis C; Di Biase L; Lakkireddy D; Burkhardt DJ; Horton RP; Natale A
    Europace; 2023 Dec; 26(1):. PubMed ID: 38225176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
    Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR;
    J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical relevance of incomplete device endothelialization after left atrial appendage closure.
    Xu J; Chen CZ; Xing J; Wang L; Tao YR; Yang B; Zhang Q; Shen YL; Hu JQ
    Int J Cardiovasc Imaging; 2023 Feb; 39(2):451-459. PubMed ID: 36136204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac Computed Tomography Angiography for Device-Related Thrombus Assessment After WATCHMAN FLX™ Occluder Device Implantation: A Single-Center Retrospective Observational Study.
    Miller T; Hana D; Patibandla S; Guzman DB; Avalon JC; Zeb I; Kadiyala M; Mills J; Balla S; Kim C; Lisle M; Kawsara M; Raybuck B; Daggubati R; Sengupta PP; Hamirani YS
    Cardiovasc Revasc Med; 2022 Aug; 41():35-46. PubMed ID: 35140053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of left atrial appendage parameters using computed tomography vs. transesophageal echocardiography for watchman device implantation: a systematic review & meta-analysis.
    Sattar Y; Kompella R; Ahmad B; Aamir M; Suleiman AM; Zghouzi M; Ullah W; Zafrullah F; Elgendy IY; Balla S; Kawsara A; Alraies MC
    Expert Rev Cardiovasc Ther; 2022 Feb; 20(2):151-160. PubMed ID: 35172121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.